Numinus Sees Integrated VC, MAPS Lead $6.0 Million Funding Round
Numinus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a
Read moreNuminus Wellness (TSX: NUMI) has received a major vote of confidence, announcing last night that it will be conducting a
Read moreNuminus Wellness (TSX: NUMI) is reporting this morning that it has sold its interest in Alto Neuroscience, a clinical-stage biopharma
Read moreThe Securities and Exchange Commission (SEC) has charged Laura Tyler Perryman, co-founder and former CEO of medical device startup Stimwave
Read moreOzempic for diabetes and Wegovy for weight loss have been so wildly in demand that the drugs boosted the GDP
Read moreModerna (NASDAQ: MRNA), the Boston-based pharmaceutical company known for its mRNA Covid-19 vaccine, has reportedly enlisted the services of former
Read moreNeuralink, a biotech company founded by Elon Musk, managed to raise $323.2 million in a fresh equity funding round based
Read moreGLP-1 medications like Ozempic and Wegovy could mean serious trouble for the quick-service restaurant (QSR) industry. Recent insights from Earnest
Read moreOn Monday, Swiss healthcare firm Roche made a significant announcement, revealing its acquisition of Telavant Holdings for a substantial upfront
Read moreA recent study conducted by researchers at Mount Sinai Medical Center in New York has revealed a potential breakthrough in
Read moreDiagnaMed Holdings (CSE: DMED) is anticipating to begin the commercialization stage of its flagship CERVAI brain health AI platform in the fourth quarter of 2023.
Read more